What Dr.Exsol does

Dr.Exsol (닥터엑솔) is a Seoul-based digital healthcare startup, founded in March 2021 by Seoul National University exercise physiology professor Song Wook (송욱), that develops evidence-based exercise content for four age-related conditions: sarcopenia, cancer survivorship, pre-diabetes, and mild cognitive impairment. The company serves South Korean seniors at risk of or diagnosed with these conditions, alongside institutional partners such as the Korean Cancer Association, MyBenefit, Lotte Confectionery, Vitamix, and the Sejong Smart City project. Dr.Exsol is a Seoul National University approved startup and operates from SNU Campus Town HERO-RO3 in Gwanak-gu and a Banpo-attached research institute in Seocho-gu.

The company's core products are four disease-specific evidence-based exercise content programs backed by 20+ years of clinical and preclinical research from Seoul National University and Texas A&M University Aging/Longevity Research Institute, supported by 52 SCI-level peer-reviewed publications and a portfolio of filed and registered patents covering motion-recognition-based sarcopenia diagnosis, cancer survivor exercise management, blood-glucose-linked exercise management, physical cognitive function measurement, and registered designs for brain yoga and cognitive-improvement exercise mats. These programs are delivered through two commercial brands: FITCovery Center, an offline hybrid recovery center combining AI motion-recognition devices (VirtualMate), AI weight training circuit, and recovery/nutrition zones; and FITMate, a brand-partner licensing and instructor certification program for third-party fitness centers. AI and machine learning are applied to motion-recognition data and accumulated user health data for personalized exercise and nutrition recommendations.

Dr.Exsol generates revenue through four streams: FITMate content licensing royalties to brand-partner fitness centers, FITCovery Center subscription and service fees, third-party platform distribution (notably via MyBenefit's VirtualMate device and mobile platform), and R&D contracts and professional services (Korean Cancer Association cancer-survivor content, Lotte Confectionery energy bar clinical trials, marine therapy center projects). The company received seed investment from Comax Venturers in March 2022 and was selected for the TIPS program in May 2022, securing up to KRW 500-700 million over two years in R&D and overseas marketing support, alongside venture company certification, corporate research institute certification, and Seoul National University Campus Town resident status.

Name

Dr.Exsol

Legal name

(주)닥터엑솔

Website

https://drexsol.co.kr

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Dr.Exsol (닥터엑솔) is a Seoul-based digital healthcare startup developing evidence-based exercise content for sarcopenia, cancer survivorship, pre-diabetes, and mild cognitive impairment, distributed via FITCovery offline centers, FITMate licensing, and AI motion-recognition platforms to seniors and partner fitness centers.

Ownership category

akta.pro rank

Product category

Digital Healthcare Services for Senior Disease Management

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Offices of Other Health Practitioners (6213)

SIC

Services-Health Services (8000)

akta.pro primary industry

Chronic Condition Lifestyle Coaching (Non-Clinical) (HSADAGAH)

akta.pro secondary industries

Virtual Preventive Care & Wellness Coaching (incl. lifestyle medicine) (HLALADAK), Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD) (HLACAGAG)

Keywords

• Digital healthcare content
• Evidence-based exercise programs
• Senior disease management
• Motion recognition rehabilitation
• Clinical exercise research

Headquarters

HQ city

Sillim

HQ country

South Korea

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Content Licensing (FITMate): Licensing of Dr.Exsol's evidence-based exercise content to brand partners (fitness centers) through the FITMate certification and education program. Partners receive content usage licenses and periodic training for instructors.
2. FITCovery Center Services: Offline health recovery center services providing customized exercise programs for the 4 major diseases, AI motion-recognition device-based training (Virtual Mate, AI weight equipment), and recovery nutrition care in a premium lounge setting. Revenue from membership/service fees at FITCovery Centers and brand partner centers.
3. Content Distribution via Platform Partnerships: Distribution of healthcare content through third-party digital health platforms (e.g., MyBenefit) and mobile platforms. Content is embedded in motion-recognition devices and mobile applications, generating revenue through platform licensing agreements.
4. R&D Services and Contracts: R&D contracts with organizations such as the Korean Cancer Association (cancer survivor exercise programs), Lotte Confectionery (energy bar clinical trials), and marine therapy centers for customized content development and validation.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Dr.Exsol develops evidence-based, clinically validated exercise content targeting four major senior-age diseases — sarcopenia, cancer survivorship, pre-diabetes, and mild cognitive impairment. The company distributes this content through company-operated FITCovery Centers (offline recovery facilities with AI motion-recognition devices), a FITMate brand partner licensing program for fitness centers, and embedded distribution via MyBenefit's VirtualMate motion-recognition platform. Revenue is generated through content licensing, FITCovery Center service fees, R&D contracts with healthcare institutions, and platform distribution agreements.

Product overview

Dr.Exsol is a digital healthcare company developing evidence-based healthcare content for 4 major diseases (sarcopenia, cancer survivors, pre-diabetes, and mild cognitive impairment). The company operates through two main brand offerings: FITCovery Center (offline centers with AI-powered circuit training and recovery zones) and FITMate (brand partner licensing program). Core products include disease-specific exercise content programs developed through 20+ years of clinical research, which are distributed via the VirtualMate motion recognition platform and various online/offline channels. The company leverages AI/machine learning for personalized exercise recommendations based on accumulated health big data.

Differentiator

Problem solved

Functional benefit

Brands

• FITCovery: Offline center brand providing evidence-based healthcare content services. Includes fitness zones and recovery zones for seniors and patients with the four major diseases.
• FITCovery Center
• FITMate

Quantifiable outcome

• Healthy life expectancy extension — Korea's healthy life is 64.4 years vs. life expectancy of 82.7 years, creating a gap of 18.3 years of post-65 elderly health need that Dr.Exsol's 4-disease exercise content addresses
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature10 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• 롯데제과 (Lotte Confectionery)minorStrategic or Co-development Partner · 1 August 2022R&D contract for clinical trials on energy bars. Dr.Exsol conducted clinical experiments on the effects of energy bar supplementation related to exercise performance and recovery.
• 해양치유센터 (Marine Therapy Centers)minorStrategic or Co-development Partner · 1 April 2022Selected for marine therapy project to develop customized metabolic syndrome and pre-diabetes management content/services at marine therapy centers. Joint content development and feedback data accumulation.
• 마이베네핏 (MyBenefit)coreStrategic or Co-development Partner · 4 February 2022Three-party MOU with MyBenefit and the Korean Cancer Association to build a healthcare platform for cancer survivors. MyBenefit provides AI/IoT/motion-recognition healthcare devices (Virtual Mate) and mobile platform; Dr.Exsol provides evidence-based exercise content; Korean Cancer Association provides cancer expertise and patient network. Joint development of cancer survivor exercise programs, big data building, and platform distribution.
• 대한암협회 (Korean Cancer Association)coreStrategic or Co-development Partner · 1 February 2022R&D contract with Korean Cancer Association for developing customized exercise programs for cancer survivors. Research conducted for prostate, colorectal, and breast cancer survivors. Joint big data building and platform expansion for cancer survivor healthcare.
• 비타믹스 (Vitamix)coreStrategic or Co-development Partner · 24 January 2022MOU for building a new concept health management platform based on exercise-nutrition solutions. Vitamix operates personalized health food brand NutriMe and participates in the Ministry of Trade, Industry and Energy personalized regulation sandbox. Dr.Exsol provides 4-disease exercise content. Joint development of AI-based personalized exercise-nutrition solutions, joint events, and linked product development for the 4 major diseases.
• Seoul National University AI Research InstitutecoreTechnology or Integration · 1 January 2022Planned collaboration with Seoul National University AI Research Institute (led by Professor Jang Byung-tak) and Graduate School of Data Science for AI-based personalized healthcare content development and prediction model algorithm development.
• (주)마이베네핏 (MyBenefit)coreStrategic or Co-development Partner · 14 May 2021Initial MOU for sarcopenia improvement and prevention content development and R&D. MyBenefit provides motion-recognition technology platform; Dr.Exsol provides exercise content. This partnership evolved into the broader cancer survivor platform MOU in 2022.

Scale indicators5 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• Hinge Health: Digital MSK and chronic pain platform combining AI motion-tracking with personalized exercise therapy. Closest analog to Dr.Exsol's motion-recognition-based exercise content for chronic conditions, though Hinge Health focuses on employer/payer channels in the US.
• Sword Health: Virtual MSK care platform using AI motion-tracking sensors and digital therapists to deliver exercise programs. Direct competitor concept: AI-guided exercise via motion recognition for musculoskeletal/chronic conditions, with similar employer and health plan distribution model.
• Omada Health: Digital chronic disease prevention platform focused on diabetes, hypertension, and pre-diabetes coaching. Comparable in addressing pre-diabetes/metabolic syndrome through behavior change and exercise content, distributed via employers and payers.
• Kaia Health: Digital therapeutics company offering AI-driven exercise programs for chronic pain, COPD, and MSK conditions via a mobile platform. Comparable motion-tracking-based personalized exercise delivery model and chronic-condition focus.
• Welldoc: Chronic disease management platform specializing in diabetes with AI-driven personalized coaching. Direct overlap with Dr.Exsol's pre-diabetes content and chronic condition lifestyle coaching approach.
• Vida Health: Virtual care platform for chronic conditions including diabetes, hypertension, and mental health with personalized coaching. Comparable in delivering multi-condition lifestyle coaching through digital + human touch model.
• MyBenefit (마이베네핏): Korean digital health platform with motion-recognition devices (VirtualMate) and AI/IoT/Big Data integration. Strategic partner of Dr.Exsol, but operates as a parallel/competing platform with its own exercise content; directly comparable Korean-market digital health delivery model.

Broad incumbents

• Noom: Consumer digital health platform for weight management and chronic disease prevention with coaching-led behavior change. Comparable evidence-based lifestyle coaching concept but operates at much larger scale across multiple consumer health verticals.

Emerging players

• EmoCog (이모코그): Korean digital therapeutics company for degenerative brain disease, identified as a Dr.Exsol 'family company'. Direct overlap with Dr.Exsol's mild cognitive impairment content; emerging Korean player in the same cognitive health vertical.
• Dacadoo: Swiss digital health engagement platform with health scoring and lifestyle coaching for chronic disease prevention. Comparable evidence-based digital health scoring concept and chronic condition focus, but broader in scope and available globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dr.Exsol